SOUTHWEST ONCOLOGY GROUP

西南肿瘤集团

• 批准号: 3556201
• 负责人: THOMAS Patrick MILLER
• 金额: $ 23.64万
• 依托单位: UNIVERSITY OF ARIZONA
• 依托单位国家: 美国
• 财政年份: 1978
• 资助国家: 美国
• 起止时间: 1978-01-01 至 1992-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3556201
• 关键词: Hodgkin's disease; Mycobacterium bovis; adult human (21+); bladder neoplasm; bleomycin; breast neoplasms; carmustine; cis platinum compound; colon neoplasms; combination cancer therapy; cooperative study; cyclophosphamide; doxorubicin; drug metabolism; drug screening /evaluation; fluorouracil; head /neck neoplasm; human subject; human therapy evaluation; imaging /visualization /scanning; leukemia; lung neoplasms; lymphoma; melanoma; melphalan; metastasis; monoclonal antibody; multiple myeloma; neoplasm /cancer chemotherapy; neoplasm /cancer immunotherapy; neoplasm /cancer radiation therapy; neoplasm /cancer radionuclide diagnosis; neoplasm /cancer surgery; neoplasm /cancer thermotherapy; ovary neoplasms; pediatric neoplasm /cancer; phosphamide; prednisone; radiotracer; sarcoma; skin neoplasms; stromal cells; testis neoplasms; vincristine

This grant application requests funding to continue support for investigators at the Arizona Cancer Center to improve cancer treatment for humans by participation in the Southwest Oncology Group. Specific aims include: 1. To develop scientific leads using the laboratories and clinics of the Arizona Cancer Center (University of Arizona) worthy of testing in a national cooperative group (Southwest Oncology Group). 2. To incorporate these pilot experiences into large confirmatory or randomized multi-institution trials. 3. To increase participation in Southwest Oncology Group trials by entering a larger number of patients on studies. 4. To continue and expand our already large commitment to scientific leadership of the Southwest Oncology Group. 5. To make available state-of-the-art treatment to a large proportion of patients throughout the State of Arizona by increasing the number of community clinical research satellites interested in participating in Southwest Oncology Group studies.

该赠款申请要求资金继续支持 亚利桑那癌症中心的研究人员改善癌症 通过参与西南肿瘤学来治疗人类 团体。 具体目的包括： 1。使用实验室和诊所开发科学潜在客户 亚利桑那癌症中心（亚利桑那大学）值得 在国家合作组织（西南肿瘤学）中进行测试 团体）。 2。将这些飞行员​​经验纳入大型确认 或随机多机构试验。 3。增加参与西南肿瘤学小组试验 通过在研究上输入更多的患者。 4。继续并扩大我们已经庞大的承诺 西南肿瘤学小组的科学领导。 5。为大型提供最先进的治疗 整个亚利桑那州的患者比例 增加社区临床研究卫星的数量 有兴趣参加西南肿瘤学小组研究。